Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.5 EUR
30.33 M EUR
506.03 M EUR
46.39 M
About Core Laboratories Inc.
Sector
Industry
CEO
Lawrence V. Bruno
Website
Headquarters
Houston
Founded
2012
ISIN
US21867A1051
FIGI
BBG01GHX8HN1
Core Laboratories Inc. provides proprietary and patented reservoir description and production enhancement services. It operates through the Reservoir Description and Production Enhancement segments. The Reservoir Description segment engages in petroleum reservoir analysis for energy. The Production Enhancement segment includes services and manufactured products associated with reservoir well completions, perforations, stimulation, production and well abandonment. The company was founded in 1936 and is headquartered in Houston, TX.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Core Laboratories Inc. stocks are traded under the ticker HJ1.
We've gathered analysts' opinions on Core Laboratories Inc. future price: according to them, HJ1 price has a max estimate of 15.39 EUR and a min estimate of 11.97 EUR. Watch HJ1 chart and read a more detailed Core Laboratories Inc. stock forecast: see what analysts think of Core Laboratories Inc. and suggest that you do with its stocks.
Yes, you can track Core Laboratories Inc. financials in yearly and quarterly reports right on TradingView.
Core Laboratories Inc. is going to release the next earnings report on Oct 22, 2025. Keep track of upcoming events with our Earnings Calendar.
HJ1 earnings for the last quarter are 0.16 EUR per share, whereas the estimation was 0.16 EUR resulting in a 1.94% surprise. The estimated earnings for the next quarter are 0.16 EUR per share. See more details about Core Laboratories Inc. earnings.
Core Laboratories Inc. revenue for the last quarter amounts to 110.49 M EUR, despite the estimated figure of 109.62 M EUR. In the next quarter, revenue is expected to reach 111.86 M EUR.
HJ1 net income for the last quarter is 9.03 M EUR, while the quarter before that showed −142.35 K EUR of net income which accounts for 6.44 K% change. Track more Core Laboratories Inc. financial stats to get the full picture.
Yes, HJ1 dividends are paid quarterly. The last dividend per share was 0.01 EUR. As of today, Dividend Yield (TTM)% is 0.32%. Tracking Core Laboratories Inc. dividends might help you take more informed decisions.
Core Laboratories Inc. dividend yield was 0.23% in 2024, and payout ratio reached 5.97%. The year before the numbers were 0.23% and 5.09% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 25, 2025, the company has 3.5 K employees. See our rating of the largest employees — is Core Laboratories Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Core Laboratories Inc. EBITDA is 50.40 M EUR, and current EBITDA margin is 12.13%. See more stats in Core Laboratories Inc. financial statements.
Like other stocks, HJ1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Core Laboratories Inc. stock right from TradingView charts — choose your broker and connect to your account.